AI & Emerging Technology

DJ Steve Aoki and Bombay Sapphire team up for the E1 electric boat race, merging high-octane sport with a new wave of sustainable luxury in Ibiza.

Preliminary data shows IBI363 achieved an 86.4% response rate in advanced lung cancer patients who typically respond poorly to current immunotherapies.

With overwhelming shareholder approval, Savanna Capital is set to become North American Silver Corp., targeting a promising Mexican silver project.

A breakthrough system grows larger, more complex human gut tissues twice as fast, promising to revolutionize drug testing and regenerative medicine.

A Seattle biotech's award-winning vaccine for a deadly fever is now in human trials, powered by innovative tech that could change global vaccine deployment.

The battery maker is leveraging its solid-state tech and key global partners to break the flight time and power limits of commercial and defense drones.

New Callisto protocol for Oxford Nanopore achieves diagnostic-grade accuracy, paving the way for routine whole genome sequencing in clinical settings.

The vertical farming firm signs a letter of intent to acquire a major Illinois fabricator, signaling a bold move into the drone and AI hardware markets.

Taiga Motors begins global deliveries of its new Orca WX3, signaling a major shift towards silent, accessible electric watercraft in a gas-powered world.

After a record 2025, investors are watching if UP Fintech can sustain its growth amid global market turmoil and rising interest rates.

A new partnership aims to end fragmented payment systems for UK merchants, promising a single platform for sales, stock, and transactions.

A new Global Elite partnership signals a major shift from legacy systems to integrated, cloud-native security for modern enterprises worldwide.

With its stock value plummeting, an Israeli tech firm is launching its Perfecta 3D-printed meats in the U.S., hoping to win over a skeptical market.

A new clinical trial is testing a device that uses electricity to deliver chemo directly into tumors, a strategy that could revolutionize treatment.

Telecom leaders meet as a chilling investment climate clashes with rising network demands, putting Canada's status as a digital leader at risk.

A new partnership between Ohmium and RenewCO₂ aims to turn harmful CO₂ emissions into valuable products, pioneering a circular carbon economy.

Led by OrbiMed, the financing will propel Accro's promising oral RIPK2 inhibitor for Ulcerative Colitis into a pivotal Phase IIb clinical trial.

A new partnership aims to solve one of biotech's biggest challenges, expanding powerful gene therapies beyond the liver to treat a wider range of diseases.

A biotech firm has hatched healthy chicks from artificial eggs, a breakthrough paving the way for de-extinction and a new era in avian conservation.

The P2P texting pioneer is now employee-owned, a strategic move poised to reshape campaign tech and champion authentic connection in the 2026 midterms.